SENSEX NIFTY

Drugs

Sep 17, 2014 at 13:21 | Source: Moneycontrol.com
Beryl Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has not declared any dividend for the year.
Sep 17, 2014 at 11:47 | Source: CNBC-TV18
The size of Glargine is expected to be around USD 3-4 billion globally.
Sep 17, 2014 at 09:58 | Source: Moneycontrol.com
Amoxicillin for oral suspension is the generic equivalent to the reference listed drug product (RLD) of Teva and indicated in the treatment of infections due to susceptible Betalactamase-negative strains of the designated micro-organisms.
Sep 16, 2014 at 18:00 | Source: CNBC-TV18
This is a long-term deal and rings in positives for Lupin in terms of fixed milestone payments and expansions in emerging markets. Besides, they do not need to invest in building up a front-end field force in these emerging markets.
Sep 16, 2014 at 14:23 | Source: Moneycontrol.com
"Zydus Cadila has received tentative approval from the US Food and Drug Administration (US FDA) to market (anti-diabetic drug) Glipizide extended release tablets in the strength of 2.5 mg, 5 mg and 10 mg," said the company in its filing.
Sep 16, 2014 at 12:13 | Source: Moneycontrol.com
Zydus Cadila has received tentative approval from USFDA to market Glipizide extended-release tablets in the strength of 2.5 mg, 5 mg and 10 mg. The drug falls in the anti-diabetic segment.
Sep 16, 2014 at 08:08 | Source: Reuters
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
Sep 15, 2014 at 11:00 | Source: Moneycontrol.com
US-based drug maker Gilead Sciences may join hands with atleast five Indian generic pharmaceutical companies for manufacturing and selling cheaper versions of its new hepatitis C medicines.
Sep 12, 2014 at 13:42 | Source: Moneycontrol.com
Taro has recalled two lots of a key drug on September 2, citing failed content uniformity specifications, according to drug regulator. The drug contributes nearly 5 percent of Taro's sales, analysts say.
Sep 12, 2014 at 12:54 | Source: Moneycontrol.com
During the last earnings call, Strides Arcolab had highlighted that from USD 390 million of receivables from Mylan, it expects contingent holdback (of USD 250 million) to get released in Q2 FY15. With 20 days left for Q2FY15 end, dividend could be a near-term catalyst.
Messages on Drugs »

maximindia

Platinum Member

563 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th

Market Statistician

Platinum Member

10070 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th

News across the web »
Sep 17, 2014 at 19:57 | Source: NDTV Profit
Sep 17, 2014 at 11:16 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.